|
|
News Breaks
|
November 23, 2009
|
| 09:01 EDT |  | SGEN |
| theflyonthewall.com: | Seattle Genetics and Agensys expand collaboration | | Seattle Genetics and Agensys, an affiliate of Astellas, announced today an expansion of the companies’ antibody-drug conjugate, or ADC, collaboration. Under the amended agreement, Agensys will pay a $12M fee for exclusive rights to ADC licenses against additional antigen targets. Seattle Genetics also receives an option to co-develop another ADC at the time of investigational new drug submission. :theflyonthewall.com |
|
|
News For SGEN From The Last 14 Days Check below for free stories on SGEN the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
